 |
|
|
|
|
|
|
| Article 1 to 10 out of 16 concerning Bayer Healthcare AG
|
-
Bayer Strengthens Research and Development
(16 Dec 2008)
Pharmaceutical pipeline is well filled, with 50 projects currently in phases I to III of clinical testing
The Bayer Group is to further expand its research and development activities despite the current financial and economic crisis. "The task now is to set the right course. Only through innovation can our company generate the growth that is essential ...
-
Bayer completes acquisition of U.S. biologics manufacturing facility from Novartis
(17 Sep 2007)
Bayer Schering Pharma AG, Germany, has completed the acquisition of a biologics manufacturing facility in Emeryville, California from Novartis. Bayer will manufacture its multiple sclerosis drug Betaseron® at the Emeryville site, retain full control ...
-
Bayer HealthCare announces concrete plans for the global synergy goals and job cuts
(06 Mar 2007)
Bayer HealthCare published concrete plans regarding the previously announced synergy goals. The integration of the activities of the former Schering AG, Germany, with the Pharma division of Bayer HealthCare shall result in annual savings of EUR 700 ...
-
Bayer HealthCare strengthens presence in Eastern Europe
(22 Feb 2007)
More than 200 staff for Marketing and Sales integrated in Russia, Belarus, the Ukraine and Kazakhstan
Bayer HealthCare has taken over the marketing and distribution network of its partner Pharmonyx Ltd. in Russia, Belarus, the Ukraine and Kazakhstan. Pharmonyx has been responsible for marketing and distributing BHC's products in these countries ...
-
Bayer Outlines New Global R&D Structures
(13 Nov 2006)
U.S. Pharma Sites and Future Headquarters
Bayer HealthCare announced a structural realignment of its global pharmaceutical research and development organization. The company also outlined its future U.S. pharma site plan, and said that New Jersey will be home to its U.S. headquarters for ...
-
Bayer HealthCare Acquires Western OTC Cough and Cold Business of Topsun Science and Technology
(27 Oct 2006)
Bayer HealthCare (BHC) and Topsun Science and Technology Co., Ltd. together announced that BHC's Consumer Care Division has signed an agreement in China to acquire the Western over-the-counter (OTC) cough and cold portfolio of Topsun Science and ...
-
Bayer and Schering optimistic about their common future
(23 Jun 2006)
Following the success of Bayer's takeover offer for Schering, the two companies are confident about their common future. "We will combine two successful pharmaceutical companies to form a single, even more powerful unit and create a leading global ...
-
Bayer HealthCare and Nuvelo begin second pivotal phase III trial of alfimeprase
(12 Apr 2006)
Bayer HealthCare (BHC) and Nuvelo Inc. announced that they had begun patient enrollment in a second pivotal phase III clinical trial of alfimeprase for the treatment of acute peripheral arterial occlusion (PAO). This phase III trial, known as NAPA-3 ...
-
Schering AG supports Bayer offer
(27 Mar 2006)
New global specialized pharma company "Bayer Schering Pharma"
The Executive Board of Schering AG, Germany announced that it will support a voluntary public offer by Bayer AG to acquire all of the outstanding shares of Schering AG for a price of EUR 86 in cash which it will recommend to its shareholders after ...
-
Bayer HealthCare concludes divestment of anti-infectives research to Santo Holding AG
(24 Mar 2006)
Jobs in Wuppertal to be retained
Bayer HealthCare (BHC) has concluded the divestment of its anti-infectives research to Santo Holding AG, Stuttgart, Germany. Bayer HealthCare will retain a minority holding in the newly established company AiCuris GmbH & Co. KG. The majority owners ...
|
|
|
|
|
Top